A detailed history of Principal Financial Group Inc transactions in Geron Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 49,762 shares of GERN stock, worth $198,550. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49,762
Previous 91,134 45.4%
Holding current value
$198,550
Previous $386,000 41.71%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$4.17 - $4.99 $172,521 - $206,446
-41,372 Reduced 45.4%
49,762 $225,000
Q2 2024

Jul 29, 2024

SELL
$3.1 - $5.09 $121,256 - $199,095
-39,115 Reduced 30.03%
91,134 $386,000
Q1 2024

Apr 29, 2024

BUY
$1.75 - $3.44 $1,067 - $2,098
610 Added 0.47%
130,249 $429,000
Q4 2023

Feb 07, 2024

BUY
$1.74 - $2.31 $929 - $1,233
534 Added 0.41%
129,639 $273,000
Q3 2023

Nov 02, 2023

BUY
$2.11 - $3.28 $3,867 - $6,012
1,833 Added 1.44%
129,105 $273,000
Q2 2023

Aug 07, 2023

BUY
$1.97 - $3.69 $45,654 - $85,515
23,175 Added 22.26%
127,272 $408,000
Q1 2023

May 09, 2023

BUY
$2.14 - $3.4 $14,231 - $22,610
6,650 Added 6.82%
104,097 $225,000
Q4 2022

Feb 09, 2023

BUY
$2.03 - $2.42 $101,146 - $120,578
49,826 Added 104.63%
97,447 $235,000
Q3 2022

Nov 09, 2022

BUY
$1.67 - $2.94 $4,455 - $7,843
2,668 Added 5.94%
47,621 $111,000
Q2 2022

Aug 10, 2022

BUY
$1.19 - $1.65 $24,900 - $34,526
20,925 Added 87.09%
44,953 $70,000
Q1 2022

May 09, 2022

SELL
$0.99 - $1.6 $2,318 - $3,747
-2,342 Reduced 8.88%
24,028 $33,000
Q4 2021

Feb 09, 2022

BUY
$1.22 - $1.72 $1,156 - $1,630
948 Added 3.73%
26,370 $32,000
Q3 2021

Nov 09, 2021

SELL
$1.2 - $1.5 $11,251 - $14,064
-9,376 Reduced 26.94%
25,422 $35,000
Q2 2021

Aug 10, 2021

BUY
$1.25 - $1.83 $8,080 - $11,829
6,464 Added 22.81%
34,798 $49,000
Q1 2021

May 10, 2021

BUY
$1.52 - $2.1 $15,979 - $22,077
10,513 Added 58.99%
28,334 $45,000
Q4 2020

Feb 08, 2021

SELL
$1.55 - $2.05 $5,395 - $7,136
-3,481 Reduced 16.34%
17,821 $28,000
Q3 2020

Nov 06, 2020

BUY
$1.59 - $2.19 $246 - $339
155 Added 0.73%
21,302 $37,000
Q2 2020

Aug 05, 2020

BUY
$1.05 - $2.18 $238 - $494
227 Added 1.09%
21,147 $46,000
Q1 2020

May 12, 2020

BUY
$0.89 - $1.49 $5,587 - $9,354
6,278 Added 42.88%
20,920 $25,000
Q4 2019

Feb 05, 2020

SELL
$1.27 - $1.54 $38,317 - $46,463
-30,171 Reduced 67.33%
14,642 $20,000
Q3 2019

Nov 13, 2019

BUY
$1.15 - $1.59 $4,759 - $6,581
4,139 Added 10.18%
44,813 $60,000
Q2 2019

Aug 12, 2019

SELL
$1.37 - $2.02 $12,683 - $18,701
-9,258 Reduced 18.54%
40,674 $57,000
Q1 2019

May 10, 2019

SELL
$1.01 - $1.83 $347 - $629
-344 Reduced 0.68%
49,932 $83,000
Q4 2018

Feb 14, 2019

SELL
$0.98 - $1.85 $3,607 - $6,809
-3,681 Reduced 6.82%
50,276 $50,000
Q3 2018

Nov 14, 2018

BUY
$1.76 - $6.38 $12,003 - $43,511
6,820 Added 14.47%
53,957 $95,000
Q2 2018

Aug 13, 2018

SELL
$3.29 - $4.82 $3,776 - $5,533
-1,148 Reduced 2.38%
47,137 $0
Q1 2018

May 14, 2018

SELL
$1.81 - $5.98 $1,475 - $4,873
-815 Reduced 1.66%
48,285 $205,000
Q4 2017

Feb 13, 2018

BUY
$1.8 - $2.32 $46,855 - $60,391
26,031 Added 112.84%
49,100 $89,000
Q3 2017

Nov 02, 2017

BUY
$1.99 - $2.65 $45,907 - $61,132
23,069
23,069 $50,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.51B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.